Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Lancut

7 clinical trials in Lancut, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Lancut at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Lancut

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dolutegravir Sodium
  • Sponsor:Viiv Healthcare UK Limited
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Opella Healthcare Group S.A.S.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ruzasvir
  • Sponsor:Atea Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bepirovirsen
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Bepirovirsen
  • Sponsor:GlaxoSmithKline Biologicals

Chronic hepatitis B+1

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bepirovirsen
  • Sponsor:Glaxosmithkline Research & Development Limited

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Lancut

What the registry says about research in the country

01 Viral Infections Research

Clinical studies focusing on severe viral lung infections are evaluating novel therapeutic approaches using tozorakimab for patients requiring supplemental oxygen support. This research aims to prevent disease progression and improve patient outcomes.

  • Respiratory Support Interventions
  • Disease Progression Prevention
  • Critical Care Management

These trials represent significant advancement in treating severe respiratory infections requiring hospitalization.

02 Hepatitis B Research

Multiple clinical trials are investigating innovative treatments for chronic Hepatitis B, including studies of antisense oligonucleotides and targeted immunotherapy approaches for patients on existing nucleos(t)ide analogue therapy.

  • Antiviral Treatments
  • Immunotherapy Solutions
  • Long-term Response Monitoring

Research focuses on achieving functional cure and evaluating treatment durability in chronic HBV patients.

03 Treatment Durability Studies

Long-term follow-up research examining the sustainability of therapeutic responses in hepatitis treatment, particularly focusing on bepirovirsen and its effectiveness in achieving lasting results.

  • Response Monitoring
  • Treatment Effectiveness
  • Patient Outcomes

These studies are crucial for understanding the long-term benefits of new therapeutic approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.